The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

Drug candidate bepirovirsen delivered a functional cure rate for 19% of patients in what the company sees as a breakthrough ...

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...

Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...

World Hepatitis Day 2020: According to The World Health Organisation, an estimated 40 million people are chronically affected by Hepatitis B and 6 to 12 million people by Hepatitis C in India.

Researchers report that a new drug, bepirovirsen, could revolutionize hepatitis B treatment by making the virus undetectable ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...